Name | Number of supported studies | Average coverage | |
---|---|---|---|
non-classical monocyte | 3 studies | 18% ± 3% |
Insufficient scRNA-seq data for expression of CHMP6 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 885.10 | 1445 / 1445 | 100% | 15.02 | 183 / 183 |
skin | 100% | 963.81 | 1809 / 1809 | 100% | 29.48 | 471 / 472 |
pancreas | 100% | 502.57 | 327 / 328 | 100% | 20.34 | 178 / 178 |
thymus | 100% | 889.06 | 653 / 653 | 100% | 32.39 | 603 / 605 |
prostate | 100% | 900.57 | 245 / 245 | 100% | 23.75 | 500 / 502 |
lung | 100% | 868.04 | 578 / 578 | 100% | 22.69 | 1150 / 1155 |
kidney | 100% | 851.33 | 89 / 89 | 99% | 26.01 | 895 / 901 |
stomach | 100% | 646.87 | 359 / 359 | 99% | 18.85 | 284 / 286 |
intestine | 100% | 910.92 | 966 / 966 | 99% | 20.14 | 523 / 527 |
brain | 99% | 532.33 | 2619 / 2642 | 100% | 30.11 | 705 / 705 |
liver | 100% | 786.43 | 226 / 226 | 99% | 22.59 | 402 / 406 |
uterus | 100% | 949.49 | 170 / 170 | 99% | 19.97 | 453 / 459 |
breast | 100% | 942.32 | 459 / 459 | 99% | 22.66 | 1102 / 1118 |
bladder | 100% | 856.62 | 21 / 21 | 98% | 22.73 | 496 / 504 |
ovary | 98% | 707.67 | 177 / 180 | 100% | 20.35 | 429 / 430 |
adrenal gland | 100% | 781.90 | 258 / 258 | 97% | 16.88 | 222 / 230 |
adipose | 100% | 840.56 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 36.32 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 24.98 | 29 / 29 |
muscle | 100% | 1243.72 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 1114.13 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 17.64 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 10.97 | 1 / 1 |
blood vessel | 100% | 770.02 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 641.97 | 852 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 98% | 828.42 | 912 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0001778 | Biological process | plasma membrane repair |
GO_0051469 | Biological process | vesicle fusion with vacuole |
GO_0042176 | Biological process | regulation of protein catabolic process |
GO_0039702 | Biological process | viral budding via host ESCRT complex |
GO_0036258 | Biological process | multivesicular body assembly |
GO_0061763 | Biological process | multivesicular body-lysosome fusion |
GO_1901673 | Biological process | regulation of mitotic spindle assembly |
GO_0016236 | Biological process | macroautophagy |
GO_1903541 | Biological process | regulation of exosomal secretion |
GO_0043162 | Biological process | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway |
GO_0061952 | Biological process | midbody abscission |
GO_0090148 | Biological process | membrane fission |
GO_0006997 | Biological process | nucleus organization |
GO_0032511 | Biological process | late endosome to vacuole transport via multivesicular body sorting pathway |
GO_0046761 | Biological process | viral budding from plasma membrane |
GO_1902774 | Biological process | late endosome to lysosome transport |
GO_0071985 | Biological process | multivesicular body sorting pathway |
GO_0006900 | Biological process | vesicle budding from membrane |
GO_0015031 | Biological process | protein transport |
GO_0006914 | Biological process | autophagy |
GO_0007175 | Biological process | negative regulation of epidermal growth factor-activated receptor activity |
GO_1904902 | Biological process | ESCRT III complex assembly |
GO_0097352 | Biological process | autophagosome maturation |
GO_0007080 | Biological process | mitotic metaphase chromosome alignment |
GO_0031468 | Biological process | nuclear membrane reassembly |
GO_0000815 | Cellular component | ESCRT III complex |
GO_0030496 | Cellular component | midbody |
GO_0005643 | Cellular component | nuclear pore |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0000776 | Cellular component | kinetochore |
GO_0000421 | Cellular component | autophagosome membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005828 | Cellular component | kinetochore microtubule |
GO_0005829 | Cellular component | cytosol |
GO_0005771 | Cellular component | multivesicular body |
GO_1904930 | Cellular component | amphisome membrane |
GO_0010008 | Cellular component | endosome membrane |
GO_0032585 | Cellular component | multivesicular body membrane |
GO_0005765 | Cellular component | lysosomal membrane |
GO_0044877 | Molecular function | protein-containing complex binding |
GO_0005515 | Molecular function | protein binding |
Gene name | CHMP6 |
Protein name | Charged multivesicular body protein 6 (Chromatin-modifying protein 6) (Vacuolar protein sorting-associated protein 20) (Vps20) (hVps20) Charged multivesicular body protein 6 |
Synonyms | VPS20 |
Description | FUNCTION: Probable core component of the endosomal sorting required for transport complex III (ESCRT-III) which is involved in multivesicular bodies (MVBs) formation and sorting of endosomal cargo proteins into MVBs. MVBs contain intraluminal vesicles (ILVs) that are generated by invagination and scission from the limiting membrane of the endosome and mostly are delivered to lysosomes enabling degradation of membrane proteins, such as stimulated growth factor receptors, lysosomal enzymes and lipids. The MVB pathway appears to require the sequential function of ESCRT-O, -I,-II and -III complexes. ESCRT-III proteins mostly dissociate from the invaginating membrane before the ILV is released. The ESCRT machinery also functions in topologically equivalent membrane fission events, such as the terminal stages of cytokinesis and the budding of enveloped viruses (HIV-1 and other lentiviruses). ESCRT-III proteins are believed to mediate the necessary vesicle extrusion and/or membrane fission activities, possibly in conjunction with the AAA ATPase VPS4. In the ESCRT-III complex, it probably serves as an acceptor for the ESCRT-II complex on endosomal membranes. |
Accessions | ENST00000572778.5 ENST00000325167.9 I3L3E4 ENST00000572525.5 Q96FZ7 I3L4G8 ENST00000571457.1 I3L4A1 |